Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.47 |
| ▸ | NQO2 | P16083 | 3/20 | 0.43 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26500173 | 0.82 | HSD17B1 (0.58) | HSD17B1HSD17B2CYP3A4CYP2C19MEN1 | |
| SCHEMBL26500184 | 0.82 | HDAC3 (0.43) | CYP3A4CYP2C9CYP2C19RAB9APOLB | |
| SCHEMBL26500172 | 0.80 | HSD17B1 (0.47) | HSD17B1HSD17B2RAB9AMEN1KMT2A | |
| SCHEMBL9312637 | 0.80 | ADORA3 (0.53) | MEN1KMT2APOLBADORA2AADORA1 | |
| SCHEMBL498650 | 0.79 | HSD17B1 (0.65) | HSD17B1HSD17B2NQO2CYP2E1CYP3A4 | |
| SCHEMBL26500204 | 0.79 | HSD17B1 (0.46) | HSD17B1HSD17B2RAB9AMEN1KMT2A | |
| SCHEMBL14190035 | 0.77 | HSD17B1 (0.62) | HSD17B1HSD17B2NQO2CYP2E1CYP3A4 | |
| SCHEMBL2242666 | 0.77 | HSD17B1 (0.62) | HSD17B1HSD17B2NQO2CYP2E1CYP3A4 | |
| SCHEMBL7591649 | 0.77 | HSD17B1 (0.62) | HSD17B1HSD17B2NQO2CYP2E1CYP3A4 | |
| SCHEMBL7587610 | 0.77 | HSD17B1 (0.62) | HSD17B1HSD17B2NQO2CYP2E1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132579-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230132579-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230050869-A1 | THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-8263972-B2 | Organic electroluminescent device and display medium | FUJI XEROX CO. LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8217391-B2 | Organic semiconductor transistor, method of producing the same, and electronic device | FUJI XEROX CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100276672-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY MEDIUM | FUJI XEROX CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7812172-B2 | Charge transport materials; for organic electronic devices such as organic photoreceptors, organic electroluminescence devices, organic transistors, and organic optical memories | FUJI XEROX CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100243995-A1 | ORGANIC SEMICONDUCTOR TRANSISTOR, METHOD OF PRODUCING THE SAME, AND ELECTRONIC DEVICE | FUJI XEROX CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100137611-A1 | THIAZOLOTHIAZOLE DERIVATIVE | FUJI XEROX CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100276672-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY MEDIUM | L1CAM, OR10J3, ALK | HSD17B1 576/4885HSD17B2 268/4885NQO2 2457/4885 |
| US-20100137611-A1 | THIAZOLOTHIAZOLE DERIVATIVE | BCAT1, ABAT, BCAT2 | HSD17B1 34/4885HSD17B2 40/4885NQO2 1458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.